Illegal academic promotion has been punished across provinces!

Recently, a pharmaceutical CSO company in Shenzhen was punished by the Shanghai market supervision and Administration Bureau Wang Peng, vice president of yaomaitong, said that the real academic promotion is to pass the diagnosis and treatment plan and concept contained in the medicine to doctors through department meetings, academic conferences and other ways, and empower doctors, so as to obtain natural sales of products If it is not for the purpose of improving the awareness rate, diagnosis rate and cure rate of the disease, even in the form of academic promotion, it can not stand the examination at all He said that in 2019, the strength, scope and determination of medicine anti-corruption are unprecedented The state health insurance bureau and the Ministry of Finance jointly launched the accounting quality verification of 77 pharmaceutical enterprises; the state health insurance bureau, the health care Commission, the Ministry of public security and other nine ministries and commissions jointly issued documents to strictly inspect pharmaceutical bribery; the state market supervision and Administration Bureau held a mobilization meeting to launch the special governance work against unfair competition, including the pharmaceutical industry The relevant ministries and commissions of the state perform their respective duties, but the goal is unprecedented unity, and all point to medical bribery With the cooperation of these ministries, there is less and less room for bribery to drive sales Wang Peng said that once again, the medical people reminded that the so-called "formal compliance" is not compliance There is no shortcut for medical marketing It must return to the clinic, to the products and to the truth Only real and real academic promotion is the real compliance Behind the cross provincial penalty: case collection is to stimulate the rebate of doctors' prescriptions According to the case details released by Shanghai market supervision and administration, Shenzhen is a company engaged in drug investigation and promotion In June 30, 2018, the company signed a post marketing investigation and promotion agreement with a pharmaceutical company in Shanghai According to the agreement, the parties shall be responsible for the drug investigation and promotion of a hospital in Putuo District, and a medical company in Shanghai shall recover the case report form at a price of 2200 yuan per copy and give the parties the investigation and promotion expenses In order to obtain more case reports, the parties stimulate doctors to issue prescriptions and increase drug sales by way of rebate On July 27, 2018, Sun Mou, a salesman in Shanghai, agreed with Ye Mou, a doctor in neurosurgery department of a hospital in Putuo to give him a rebate of 35 yuan / piece During the period from August 1 to October 31, 2018, doctor Ye Mou issued 92 prescriptions for patients to purchase in the pharmacy, which sold 544 prescriptions in total On November 1, 2018, Sun Mou, a salesman of the parties, paid a rebate of 19040 yuan to Ye Mou in cash as agreed Because of the concern of the patient, doctor ye returned the rebate of 19040 yuan to the salesman Sun Mou in cash on November 7, 2018 According to statistics, on November 1, 2018, the company obtained the investigation and promotion expenses of the project from a certain pharmaceutical company in Shanghai in cash from August to October, 2018, totaling 30800 yuan, so the illegal income of the parties totaled 30800 yuan Marketing compliance is a return to true academic promotion, not a variety of signs of formal compliance show that the verification of pharmaceutical academic promotion is gradually implemented to the details to check the rationality and compliance of marketing promotion Recently, the full sentence of Guo Mou, a famous invoice king in Beijing, has been exposed As a famous invoice king in Beijing Pharmaceutical circle, many pharmaceutical agents buy invoices from him for reimbursement and cash out, and the exposed cash out mode of catering and other invoices has also become the focus of attention As a result of "three pharmaceutical enterprises reported by the masses", the whole hospital in Beijing opened an academic conference for promotion The self-examination contents include the training objects, contents, time and place of the study class, training class and lecture, whether the hospital is organized in a unified way, and whether the manufacturers participate (whether the participating manufacturers or enterprises provide sponsorship or convenience such as venue, meeting affairs, exhibition board, publicity page, catering, accommodation, transportation, etc.) If it is held in other places, whether it is held in the form of tourism, whether doctors with academic titles or leadership positions participate in lectures, and whether the lecture fee exceeds the industry standard If it is the year-end dinner and annual meeting of the hospital or department, whether there are enterprises or manufacturers involved In addition to the academic conference, the content of Beijing inspection also includes whether the clinical experiment is compliant The content of self inspection includes whether the project name, hospital approval, agreement signed with the manufacturer, research start and end time, patient source, patient cost (free of charge, partial free, etc.), informed notification and signature are complete Wang Peng said that academic conferences, case collection and clinical experiments are all common forms of academic promotion Behind them are the overall promotion strategies aimed at improving the awareness rate, diagnosis rate and diagnosis and treatment rate of diseases If there is no core promotion strategy, it is just a form of rebate to stimulate doctors It is only a form of compliance, not an academic promotion This so-called form of compliance It can't stand the scrutiny and investigation of details Wang Peng pointed out that in fact, the core of drug marketing transformation is to return to real academic promotion The so-called formal compliance is not compliance, but burying thunder When the two vote system was implemented, the establishment of CSO company became the so-called solution, but now it seems that the risk is huge Recently, Wuhan State Administration of Taxation announced a series of false cases, many false CSO companies have fled, bringing hidden dangers to enterprises According to the data provided by WeChat public's prelude to the official account, according to official data, up to now, only 14 000 CSO companies in the country have survived, and only 25.4% of them have disappeared in the CSO half way Among them, 7651 were revoked their marketing business licenses, 10709 were cancelled their marketing licenses, 6840 were recorded as abnormal operations, and 1272 had official administrative punishment records Attachment: full text of the decision on administrative penalty issued by Shanghai market supervision and Administration Bureau